Moderna: BofA Global Research raises to Neutral from Underperform; raises price objective to $170 from $40
MRNA•Related News
US families, healthcare providers under strain after Trump crackdown on Haitian immigrants
XLV•
Lowe's Companies Inc <LOW.N>: Telsey Advisory Group cuts target price to $260 from $280
LOW•
Australia, NZ dollars gain from greenback's bond angst
TLT•
Backblaze prices upsized USD 175 million convertible senior notes offering due 2031
BLZE•
CIBC offers up to GBP 500,000 preference share-linked notes due 2031
CM•